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There are notable racial and ethnic disparities in the prevalence of obesity in the United States; nearly 50% of African-American adults are classified as obese compared to 35% of non-Hispanic whites 1 . GWAS have identified 36 BMI loci at statistically significant levels (P < 5 × 10 −8 ) 2-13 , 32 of which were identified in individuals of European ancestry [3] [4] [5] [6] [7] [8] and 4 of which were identified in east Asian populations 9, 10 . Large GWAS of BMI in populations of African ancestry are lacking and will be important for identifying genetic variants that are unique and/or of greater importance to this population [14] [15] [16] [17] . In this study we conducted a large GWAS metaanalysis of BMI in men and women of African ancestry to search for new loci and tested associations with common variation at the 36 known loci to better understand their relevance in populations of African ancestry.
We included 36 GWAS, totaling 39,144 men and women of African ancestry, in the stage 1 meta-analysis of as many as 3,283,202 (minor allele frequency (MAF) >1%) genotyped and imputed SNPs (Online Methods, Supplementary Tables 1-3 and Supplementary Note). After applying both study-specific and overall stage 1 genomiccontrol corrections ( Supplementary Table 2 ), 11 SNPs at five loci achieved genome-wide significance (P < 5 × 10 −8 ) (Table 1, Fig. 1 and Supplementary Fig. 1 ). Four of these loci are known BMI loci (1q25, SEC16B; 4p12, GNPDA2; 16q12, FTO; and 18q21, MC4R). The fifth locus, at 5q33 (rs7708584, approximately 27 kb upstream of GALNT10, P = 8.02 × 10 −9 ), has not been previously associated with BMI at genome-wide significant levels in any population.
We subsequently selected the 1,500 most significantly associated SNPs from stage 1 (P < 1.19 × 10 −3 ) and examined associations with BMI in an independent sample of 6,817 men and women of African ancestry from seven additional studies (stage 2) (Online Methods, Supplementary Tables 1-3 and Supplementary Note). Of these 1,500 SNPs, 179 replicated at nominal significance (P < 0.05) and had effects that were directionally consistent with those in stage 1 ( Supplementary Table 4 ). A meta-analysis of stages 1 and 2 revealed a second new locus, 6q16 (rs974417, located in an intronic region of KLHL32; stage 2 P = 3.5 × 10 −3 , combined stages 1 and 2 P = 2.2 × 10 −8 ), and confirmed our finding at rs7708584 on 5q33 near GALNT10 (stage 2 P = 9.4 × 10 −3 , combined stages 1 and 2 P = 2.2 × 10 −10 ). We further examined the associations of these two variants in a third stage composed of 25,451 individuals of African ancestry from an additional 12 studies. We found support for an association with both variants, although the strength of the association was greater for rs7708584 (GALNT10, P = 7.1 × 10 −3 ) than for rs974417 (KLHL32, P = 0.09). In combining results across all three stages (n = 71,412), rs7708584 (GALNT10) was significantly associated with BMI (P = 3.4 × 10 −11 ), whereas rs974417 (KLHL32) was nearly genome-wide significant (P = 6.9 × 10 −8 ) ( Table 1 and Fig. 2a,b) .
To identify additional new loci that may be of importance across populations, we examined the 1,500 most significant SNPs from stage 1 in publicly available data from the GIANT consortium of ~124,000 individuals European ancestry 7 (Online Methods). rs7708584 (GALNT10) was significantly associated with BMI in Europeanancestry populations (effect allele frequency (EAF) = 0.42, P = 1.2 × 10 −5 ) but rs974417 (KLHL32) was not (EAF = 0.85, P = 0.45), although it was directionally consistent. Through a meta-analysis of individuals of European and African ancestry, we identified an additional new variant at 7p15 (rs10261878) that was also associated with BMI in European-ancestry populations (GIANT EAF = 0.94, P = 2.2 × 10 −5 ). rs10261878 on 7p15 is located in an intergenic region 39 kb upstream of MIR148A (encoding miRNA-148a) and approximately 241 kb upstream of NFE2L3. This variant was positively associated with BMI in stages 1 (P = 1.7 × 10 −4 ) and 3 (P = 1.0 × 10 −3 ) in the African-ancestry GWAS, with a directionally consistent but nonsignificant association in the smaller stage 2 (P = 0.33) ( Fig. 2c and Supplementary Table 5 ). In combining results across studies of African (stages 1, 2 and 3) and European ancestry (combined n = 194,247), both rs7708584 (GALNT10, P = 5.1 × 10 −14 ) and l e t t e r s rs10261878 (MIR148A-NFE2L3, P = 1.2 × 10 −10 ) were significantly associated with BMI; rs974417 (KLHL32) did not meet the genomewide significance threshold (P = 5.7 × 10 −6 ). In individuals of east Asian descent from the AGEN 10 and RIKEN 9 consortia (n = 27,715 and n = 26,620, respectively) ( Fig. 3 , Supplementary Table 6 and Online Methods), rs7708584 (GALNT10, P = 0.002) and rs974417 (KLHL32, P = 0.023) were directionally consistent and significantly associated with BMI, whereas rs10261878 (MIR148A-NFE2L3) was neither directionally consistent nor statistically significantly associated with BMI (P = 0.053). We then examined the associations with BMI in children of African ancestry (n = 3,751) (Online Methods) and found that for all three SNPs, the associations were directionally consistent but did not reach statistical significance (P > 0.05) ( Supplementary Table 7 ).
To further understand differences by ancestral background as well as characterize the functional and genetic epidemiologic architecture of the two new BMI loci (5q33, GALNT10; and 7p15, MIR148A-NFE2L3) and the suggestive locus at 6q16 (KLHL32), we performed several additional analyses. Local ancestry adjustment (in 69% of the stage 1 sample; Online Methods) resulted in numerically similar effect estimates ( Supplementary Table 8 ), and we did not detect evidence of significant effect heterogeneity in analyses stratified by local ancestry ( Supplementary Table 9 ). We found that the three BMI loci were associated with waist circumference (among n ≈ 20,000 individuals, many of which overlap those studied here) but not with BMI-adjusted waist circumference, waist-to-hip ratio or height 18 ( Supplementary Table 10 ); however, SNPs in this region have been associated with waist-to-hip ratio in Europeans, although at SNPs that are not in linkage disequilibrium (LD) with our index SNP 19 . We found no evidence of pleiotropy with adiposity-related metabolic traits using GWAS data provided by trait-specific consortia in men and women predominantly of European ancestry [20] [21] [22] [23] [24] ( Supplementary Table 11 ).
We examined associations with BMI in our African-ancestry stage 1 sample of the index SNPs reported for the 36 previously established BMI loci in the European and Asian populations 7,9,10 ( Fig. 3 and Supplementary Table 12 ). The associations were directionally consistent with the effects reported in the original papers for 32 of the 36 established BMI loci (binomial test of direction P = 9.7 × 10 −7 ), 16 of which associated with BMI at P < 0.01 (binomial test P < 1.0 × 10 −15 ) ( Supplementary Table 12 ). 12 Previous npg l e t t e r s
Using the results from the stage 1 meta-analysis, we searched for common variants within the established loci that better captured the association of the index SNP reported in the European and Asian populations. Seven regions (PTBP2, TMEM18, DNAJC27 (previously known as RBJ), NUDT3, BDNF, FTO and MC4R) harbored at least one variant that was correlated with the index SNP in the referent population (r 2 ≥ 0.4) and was associated with BMI in the Africanancestry GWAS at a significance level that was at least one order of magnitude greater than that observed for the index SNP (Online Methods, Supplementary Table 13 and Supplementary Fig. 2a-g) . These variants were also associated with BMI in the GIANT consortium ( Supplementary Table 13 ) and are probably better markers of the biologically functional allele, at least in populations of African ancestry. We also interrogated the evidence for possible independent secondary signals by visual inspection of all P values of SNP-BMI associations for SNPs with r 2 < 0.2 within the 1-Mb region of the index SNP. We did not detect evidence of independent secondary signals at any of the known BMI loci at P < 6.7 × 10 −6 (Online Methods). For most loci, the genetic data from African-ancestry populations may assist in refining the location of the risk variant, as there are fewer markers correlated with the strongest signals and/or a more narrowed region in which any proxies reside in this population ( Supplementary Fig. 3) .
To direct us to positional candidate genes, we examined the cis associations between the index SNP and expression of gene transcripts within the flanking 1-Mb region (500 kb on each side) in human brain, subcutaneous and omental adipose tissue and liver [25] [26] [27] [28] (Online  Methods and Supplementary Table 14 ). rs7708584 near GALNT10 showed nominally significant (P < 0.05) associations with GALNT10 expression (for two of the three transcripts available) in liver, omental fat and subcutaneous fat (P = 0.048, P = 0.00010 and P = 0.00017, respectively). We also found suggestive cis associations for rs10261878 near NFE2L3 with NFE2L3 expression in the same three tissues (P = 0.039, P = 0.015 and P = 0.036 for liver, omental fat and subcutaneous fat, respectively). However, despite the consistent associations observed for our lead SNPs in the GALNT10 and NFE2L3 loci, other nearby SNPs showed stronger association with the expression levels of the respective transcripts ( Supplementary Fig. 4 ). Subsequent conditional analyses adjusting for the most significant expression quantitative trait locus (eQTL) SNP in the region abolished the cis associations between the BMI-associated SNPs and the respective transcript expression levels ( Supplementary Table 15 ). Taken together, these eQTL analyses could not confirm that the identified BMI-associated SNPs affect GALNT10 and NFE2L3 expression directly. We did not find nonsynonymous SNPs in GALNT10, NFE2L3 or KLHL32 that were correlated (r 2 > 0.2) with the most significant SNPs in the 1000 Genomes Project African-ancestry populations (AFR). However, we did detect a number of correlated SNPs (r 2 > 0.5) in regulatory sequences determined on the basis of overlapping chromatin marks in multiple cell types, including brain and adipose tissue (Online Methods). Many of these SNPs (or good proxies in the 1000 Genomes Project AFR, with an r 2 range of 0.59-1.0), which are located in putative enhancer and promoter regions, had only marginally weaker associations in stage 1 than the most significant SNPs reported in these regions (Supplementary Tables 16-19 and Supplementary Fig. 5a-c) . Together these data suggest that the biologically relevant variants in all three regions may be regulatory in function.
The variant rs7708584 at chromosome 5q33 is located upstream of GALNT10 (encoding UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 10), which catalyzes the first step in the synthesis of mucin-type oligosaccharides (Supplementary Note). GALNT10 is highly expressed in the small intestine and at intermediate levels in the stomach, pancreas, ovary, thyroid gland and spleen 29 . Suggestive associations between BMI and GALNT10 have been observed in a smaller sample of African Americans 14 that was included in the present stage 1 meta-analysis, although the lead SNP differed (rs2033195) and showed only moderate LD (r 2 = 0.27) with the lead SNP we discovered here. The variant at 7p15, rs10261878, is intergenic and located 39 kb from a microRNA-encoding gene (MIR148A), which has been found to be significantly upregulated during adipogenesis 30 , as well as in human adipocytes 31 . In addition, human miR-148a has been shown to regulate CCKBR (encoding cholecystokinin B receptor), which has been reported to have a regulatory role in the control of food intake 32 . The next closest gene (241 kb from rs10261878) is NFE2L3 (encoding the nuclear factor (erythroid-derived 2)-like 3), a transcription factor that binds to antioxidant response elements of target genes and seems to have a role in differentiation, inflammation and carcinogenesis 33 .
The most significant SNP at chromosome 6q16 (rs974417) is intronic in KLHL32 (encoding kelch-like 32). Kelch-like genes have propeller domains that bind substrate proteins, promoting substrate ubiquitination, which modulates protein function. We also detected evidence of recent positive selection in and downstream of KLHL32 (Supplementary Figs. 6-9 and Supplementary Note).
In the largest GWAS meta-analysis of African-ancestry populations so far, we identified two new loci and one highly suggestive locus influencing BMI. The most informative SNPs in each of these three loci explain 0.10% of the variance in BMI in African-ancestry populations compared to 0.05% in Europeans and 0.03% in Asians (Table 1 and Supplementary Table 6 ). Using the most significant ancestry-specific markers from each locus, the 36 known BMI loci explain 1.30% of the variance in BMI in men and women of African ancestry compared with 1.67% and 1.25% in European and Asianancestry populations, respectively (Supplementary Tables 12 and 13) . We provide evidence for a shared genetic influence on BMI across populations, as we found directionally consistent associations with the majority of known BMI risk variants. This observation suggests that the biologically functional alleles are ancient and probably arose before migrations out of Africa. In addition, we were able to refine the window of association of some of the previously established BMI loci, which may eventually help identify the biologically functional variant(s). In this study we did not identify common variants for BMI that are likely to contribute to population differences in the prevalence of obesity. The ability to map new loci and replicate signals at established loci found in other populations reflects differences in allele frequency and effect size, which are influenced by population differences in recent demographic history and LD with the functional variant, as well as genetic and environmental modifying factors. Further studies will be needed to test the biologically functional alleles at the known loci, as well as the contribution of less common variation that have not yet been adequately surveyed by genome-wide SNP arrays. Taken together these findings demonstrate the importance of conducting genetic studies in diverse populations to identify new susceptibility loci for common traits.
METhodS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
oNLINE METhodS
Study design. We used a three-stage design consisting of a GWAS meta-analysis (stage 1), a follow-up of 1,500 SNPs (stage 2) and a focused follow-up of the three new loci (stage 3). Stage 1 included results from 36 GWAS of 39,144 men and women of African ancestry (37,956 African American and 1,188 African; Supplementary Table 1 ). We took forward the 1,500 most significantly associated SNPs (P < 0.0003) for examination in 6,817 additional men and women of African ancestry from seven GWAS (stage 2, all African American). The three SNPs that reached genome-wide significance (P < 5 × 10 −8 ) after the meta-analysis of the results from stages 1 and 2 were taken forward for further confirmation in 25,451 additional African-ancestry subjects from 12 studies. All participants in these studies provided written informed consent for the research, and approval for the study was obtained from the ethics review boards at all participating institutions. A description of each participating study as well as details regarding the measurement and collection of height and weight data are provided in the Supplementary Note.
Genotyping and quality control. Genotyping in each study was conducted using Illumina or Affymetrix genome-wide SNP arrays. The size of each study ranged from 50 to 8,421 individuals. The details of the array, genotyping qualitycontrol procedures and sample exclusions for each study that contributed data are listed in Supplementary Tables 1 and 2. Statistical analyses. In all GWAS, imputation to phased haplotype data from the founders of the CEU and YRI HapMap phase 2 samples (build 21) was performed using MACH 34 , IMPUTE2 (ref. 35) or BEAGLE 36 . SNPs with lower imputation quality scores (r 2 < 0.3) ( Supplementary Table 2 ) as well as SNPs with a small number of allele counts after stratifying by sex and case-control status were excluded from the analyses. Local ancestry, defined as the number of European chromosomes (continuous between 0 and 2), was estimated for the majority of the stage 1 African-ancestry studies ( Supplementary Table 8 ) using HAPMIX 37 . To evaluate the effect of admixture on the allele distribution between the African and European segments, we stratified the analysis of each variant by local ancestry at each locus ( Supplementary Table 9 ). Stage 1. Genome-wide association analyses were performed by each of the participating studies. BMI was regressed on age, age squared and study site (if needed) to obtain residuals, separately by sex and case-control status, if needed. Residuals were inverse-normally transformed to obtain a standard normal distribution with a mean of 0 and an s.d. of 1. For studies with unrelated subjects, each SNP was tested for additive association with BMI by regressing the transformed residuals on the number of copies of the SNP effect allele adjusting for population structure as measured by the first ten eigenvectors calculated for each study. Analyses were stratified by sex and case-control status (if needed). For studies that included related individuals, family based association tests were conducted that took into consideration the genetic relationships among the individuals. Study-specific λ values ranged from 0.95 to 1.08 (Supplementary Table 2 ). We applied genomic control in the stage 1 analysis (that is, we divided by the median of all χ 2 statistics for each study) to eliminate any remaining overdispersion before combining the GWAS in the meta-analysis. In stage 1, we conducted a fixed-effect meta-analysis using the inverse variance-weighted method implemented in the program METAL 38 . We performed a second genomic control correction of the stage 1 meta-analysis results (λ = 1.136) before selecting SNPs for follow-up.
Stages 2 and 3. The 1,500 most significant SNPs from stage 1 were examined in an additional 6,817 individuals, with each SNP being analyzed as described for stage 1 and meta-analyzed using the inverse-variance method using METAL. As in stage 1, each SNP was tested for association with BMI by regressing the transformed residuals on the number of copies of the SNP effect allele adjusting for population structure as measured by the first ten eigenvectors calculated for each study. Further testing of the three new variants was conducted in an additional 25,451 individuals (stage 3). Results from all stages were meta-analyzed using the inverse-variance method in METAL.
Examination in individuals of European ancestry.
We also examined the 1,500 most statistically significant SNPs from stage 1 in the GIANT consortium (n = 123,706 individuals of European ancestry) 7 . Of these, 1,390 were genotyped or imputed in GIANT, and 1,328 had data for n > 50,000 individuals and MAF > 1%. We conducted a meta-analysis of stages 1, 2 and 3 plus GIANT in the same manner as described above. The three new variants were also examined in the AGEN and RIKEN consortia 9,10 and the Pediatric Research Consortium (PeRC) (Supplementary Note).
Estimation of variance explained. The total fraction of variance explained was calculated using the formula 2f(1 -f) × a 2 , where f is the frequency of the variant, and a is the additive effect of the variant 3 . When calculating percentage variance explained in the African-ancestry sample for the previously discovered BMI variants that were not genome-wide significant in stage 1, we used data from the stage 1 sample; for those that were genome-wide significant in stage 1, we used data from the stage 2 sample; and for the new BMI variants, we used data from the combined stage 2 and 3 samples to avoid inflating the estimates as a result of winner's curse. When summing percentage variance explained for the 36 previously discovered BMI variants ( Supplementary  Table 12 ), we used the more informative SNP discovered through fine mapping at the seven loci ( Supplementary Table 13 ). However, for these seven variants, the stage 1 results were used, and estimates may be biased; stage 2 and 3 studies only participated in the look-up of the top SNPs from the preceding stages.
Bioinformatic analysis of the new BMI loci.
In an attempt to identify functionality in noncoding regions at the three loci, we used FunciSNP version 0.99 (ref. 39) , which systematically integrates the 1,000 Genomes SNP data (1KGP, April 2012) with chromatin features of interest. To capture regulatory elements, we used 73 different chromatin features generated by nextgeneration sequencing technologies in brain and adipose tissues from the NIH Epigenomics Roadmap 40 , as well as known DNaseI hypersensitive locations, formaldehyde-assisted isolation of regulatory elements sequencing (FAIREseq) peaks and CTCF binding sites from more than 100 different cell types, which were collected from the ENCODE data 41 . All SNPs with r 2 > 0.5 with each index SNP in the 1KGP AFR populations in a 1-Mb window around each index variant were cataloged. We used the UCSC Genome Browser (http:// genome.ucsc.edu/) to illustrate the correlated SNPs that overlap chromatin features from these tissues, as well as chromatin features from seven cell lines used in the ENCODE Project (Supplementary Fig. 5a-c) . The results from these analyses are provided in Supplementary Tables 16-19. eQTL analyses. Liver, subcutaneous fat and omental fat tissue. The determination of eQTLs in liver, subcutaneous fat and omental fat tissue have been described in detail previously 27 . In brief, liver, subcutaneous fat and omental fat tissue were obtained from patients of European ancestry who underwent bariatric surgery. Expression of a total of 39,280 oligonucleotide probes targeting transcripts representing 34,266 known and predicted genes was assessed. All patients were genotyped on a genome-wide SNP array, and association between SNPs and gene expression data was adjusted for age, race, gender and surgery year using linear regression. Results are presented in Supplementary  Table 14 and Supplementary Figure 4 .
Brain cortical tissue. We examined the cis associations (defined as genes within 1 Mb) between each of the BMI-associated SNPs and expression of nearby genes in brain (cortical tissue) 28 . The eQTL analyses have been described in detail previously (Gene Expression Omnibus (GEO) database GSE8919) 28 . In brief, DNA and RNA of neuropathologically normal cortical brain samples of 193 individuals (average age (range), 81 (65-100) years) of European ancestry were isolated and genotyped for a genome-wide SNP array, and HapMap genotypes were imputed. RNA expression was assessed for 24,357 transcripts, of which 14,078 transcripts met the quality-control criteria. Association analyses between SNPs and expression data assumed an additive model and were adjusted for sex and age at death. Results are presented in Supplementary Table 14 and Supplementary Figure 4 .
Association testing of previously established BMI loci. To characterize alleles that might better represent the biologically functional variant at the 36 previously discovered BMI loci, we searched for LD proxies among individuals npg
